Javascript must be enabled to continue!
Factors affecting in-hospital mortality in patients with chronic obstructive pulmonary disease exacerbation
View through CrossRef
Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of mortality worldwide. Acute exacerbation of COPD (AECOPD) is associated with increased mortality.
Material-Methods: We included COPD patients whom admitted to a tertiary reference center in Southern Marmara Region and hospitalized with acute exacerbation in the last two years. Medical records of the study participants were screened retrospectively in order to analyze in-hospital mortality and affecting factors on mortality in AECOPD patients.
Results: We identified a total of 242 patients hospitalized for AECOPD. Of these 86.4% (n=209) were male. The mean age of the group was 66.6±11 years old. 11 patients lost follow-up. 9 % (n=21) of the patients died. The median length of stay for hospitalization was longer in the lost patients (19.5 [min: 1-36] days vs. 10.0 [min: 1-36] days, p<0.05). The median Charlson comorbidity index was 3.0 [min: 0-12] in the overall group and total score was not different among alive and dead patients. On the other hand, mortality rate was higher in patients with concomitant lung cancer (23.8% vs. 7.5%, p<0.05). Comorbid conditions other than lung cancer were not affecting mortality outcome. C-reactive protein levels on admission were significantly higher in patients who died than the alive ones (1.96 [min: 0.3-29.8] mg/dL vs. 5.67[min: 0.3-26.4] mg/dL, p<0.05).
Conclusion: The mortality of AECOPD is high. AECOPD patients with lung cancer are at risk for poor outcome. And, high CRP levels during AECOPD episode correlate with short-term prognosis.
European Respiratory Society (ERS)
Title: Factors affecting in-hospital mortality in patients with chronic obstructive pulmonary disease exacerbation
Description:
Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of mortality worldwide.
Acute exacerbation of COPD (AECOPD) is associated with increased mortality.
Material-Methods: We included COPD patients whom admitted to a tertiary reference center in Southern Marmara Region and hospitalized with acute exacerbation in the last two years.
Medical records of the study participants were screened retrospectively in order to analyze in-hospital mortality and affecting factors on mortality in AECOPD patients.
Results: We identified a total of 242 patients hospitalized for AECOPD.
Of these 86.
4% (n=209) were male.
The mean age of the group was 66.
6±11 years old.
11 patients lost follow-up.
9 % (n=21) of the patients died.
The median length of stay for hospitalization was longer in the lost patients (19.
5 [min: 1-36] days vs.
10.
0 [min: 1-36] days, p<0.
05).
The median Charlson comorbidity index was 3.
0 [min: 0-12] in the overall group and total score was not different among alive and dead patients.
On the other hand, mortality rate was higher in patients with concomitant lung cancer (23.
8% vs.
7.
5%, p<0.
05).
Comorbid conditions other than lung cancer were not affecting mortality outcome.
C-reactive protein levels on admission were significantly higher in patients who died than the alive ones (1.
96 [min: 0.
3-29.
8] mg/dL vs.
5.
67[min: 0.
3-26.
4] mg/dL, p<0.
05).
Conclusion: The mortality of AECOPD is high.
AECOPD patients with lung cancer are at risk for poor outcome.
And, high CRP levels during AECOPD episode correlate with short-term prognosis.
Related Results
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Health Related Quality of Life in Chronic Obstructive Pulmonary Disease Patients
Health Related Quality of Life in Chronic Obstructive Pulmonary Disease Patients
Objective: To determine the health-related quality of life among patients suffering from chronic obstructive pulmonary disease.
Study Design: Cross sectional analytical study.
Plac...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Chest Wall Hydatid Cysts: A Systematic Review
Chest Wall Hydatid Cysts: A Systematic Review
Abstract
Introduction
Given the rarity of chest wall hydatid disease, information on this condition is primarily drawn from case reports. Hence, this study systematically reviews t...
An intelligent Health Monitoring System for Patients with Chronic Obstructive Pulmonary Disease based on Internet of Things
An intelligent Health Monitoring System for Patients with Chronic Obstructive Pulmonary Disease based on Internet of Things
Abstract: Chronic obstructive pulmonary disease is an important cause of global mortality. These patients are in dire need of treatments to maintain lung function and reduce consec...

